Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report – By Type (Organoids and Spheroids), Application, End Use, and Region; Segment Forecasts, 2024–2032

Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report – By Type (Organoids and Spheroids), Application, End Use, and Region; Segment Forecasts, 2024–2032

The global organoids and spheroids market size is expected to reach USD 5,117.59 million by 2032, according to a new study by Polaris Market Research. The report “Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report – By Type, Application, End Use, and Region; Segment Forecasts, 2024–2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The development of genetic editing techniques such as CRISPR/Cas-9 has enabled researchers to make precise changes to genes in stem cells, leading to the creation of organoids and spheroids that replicate disease conditions. These advancements have provided researchers with improved models for studying diseases and testing drugs, yielding valuable insights into complex cellular conditions. The combination of progress in stem cell technology and 3D culture methods has played a crucial role in the steady growth of the organoids and spheroids market. In January 2024, USC researchers developed a new human brain organoid model to study cerebellum development and the emergence of cerebellar pathology in neurological disease.

Patient-specific organoids represent a robust platform for advancing personalized medicine and driving the growth of the organoids and spheroids market by enabling the testing of potential drugs on tissues sourced from patients, which provides valuable insights into individual therapy responses. The clinical importance of organoids and spheroids in both research and clinical practice is crucial for developing personalized organoid models and furthering the progress of P4 medicine.

The development of 3D bioprinting technologies and organ-on-a-chip platforms significantly advances organoid and spheroid research. 3D bioprinting enables the creation of complex, customized tissue models with high precision, enhancing drug testing and personalized medicine. Organ-on-a-chip platforms replicate organ functions in miniature, allowing for dynamic modeling, high-throughput screening, and personalized treatment strategies. Together, these innovations improve the accuracy and relevance of biomedical research, facilitating more effective drug development and disease understanding.

Organoids and Spheroids Market Report Highlights

• Based on type, the spheroids segment held a larger share in 2023, owing to their significant use in drug discovery and disease modeling.
• The organoids segment is projected to grow rapidly during the forecast period, fueled by rising occurrences of diseases such as cancer, neurodegenerative disorders, and infectious diseases, driving demand for advanced research models.
• By application, the developmental biology segment dominated the market in 2023, owing to its application in the mechanism of organogenesis.
• North America holds the largest share in 2023, owing to the rising use of organoids and spheroids for personalized medicine.
• A few key players are 3D Biomatrix, 3D Biotek, AMS Biotechnology, Cellesce, Greiner Bio-One, and Thermo Fisher Scientific.

Polaris Market Research has segmented the organoids and spheroids market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue – USD million, 2019–2032)

Organoids

• By Type

Neural Organoids

Hepatic Organoids

Intestinal Organoids

Other Organoids

• By Method

General Submerged Method for Organoid Culture

Crypt Organoid Culture Techniques

Air Liquid Interface (ALI) Method for Organoid Culture

Clonal Organoids from Lgr5+ Cells

Brain and Retina Organoid Formation Protocol

Others

• By Source

Primary Tissues

Stem Cells

Spheroids

• By Type

Multicellular Tumor Spheroids (MCTS)

Neurospheres

Mammospheres

Hepatospheres

Embryoid Bodies

• By Method

Micropatterned Plates

Low Cell Attachment Plates

Hanging Drop Method

Others

• By Source

Cell Line

Primary Cell

iPSCs Derived Cells

By Application Outlook (Revenue – USD million, 2019–2032)

Developmental Biology

Personalized Medicine

Regenerative Medicine

Disease Pathology Studies

Drug Toxicity & Efficacy Testing

By End Use Outlook (Revenue – USD million, 2019–2032)

Biotechnology & Pharmaceutical Industries

Academic & Research Institutes

Hospitals & Diagnostic Centers

By Regional Outlook (Revenue – USD million, 2019–2032)

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa
• Latin America
• Mexico
• Brazil
• Argentina
• Rest of Latin America